First-line erlotinib and bevacizumab in patients with locally advanced and/or metastatic non-small-cell lung cancer: a phase II study including molecular imaging

A. -M. C. Dingemans*, Adrianus J. de Langen, V. van den Boogaart, Johannes T. Marcus, W. H. Backes, H. T. G. M. Scholtens, H. van Tinteren, Otto S Hoekstra, Jan Pruim, B. Brans, F. B. Thunnissen, E. F. Smit, H. J. M. Groen

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'First-line erlotinib and bevacizumab in patients with locally advanced and/or metastatic non-small-cell lung cancer: a phase II study including molecular imaging'. Together they form a unique fingerprint.

Keyphrases

INIS

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science